Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000006
UniProt IDQ9NY61
Primary gene name(s)AATF
Synonym gene name(s)CHE1, DED
Protein nameProtein AATF
Protein functionMay function as a general inhibitor of the histone deacetylase HDAC1. Binding to the pocket region of RB1 may displace HDAC1 from RB1/E2F complexes, leading to activation of E2F target genes and cell cycle progression. Conversely, displacement of HDAC1 from SP1 bound to the CDKN1A promoter leads to increased expression of this CDK inhibitor and blocks cell cycle progression. Also antagonizes PAWR mediated induction of aberrant amyloid peptide production in Alzheimer disease, presenile and senile dementia, although the molecular basis for this phenomenon has not been described to date. {ECO:0000269|PubMed:12450794, ECO:0000269|PubMed:12847090, ECO:0000269|PubMed:14627703, ECO:0000269|PubMed:15207272}.
Subcellular locationNucleus, nucleolus {ECO:0000269|PubMed:12429849}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q9NY61
Gene Ontology
(Biological Process)
Complete annatation
cell adhesion [GO:0007155];
cellular response to DNA damage stimulus [GO:0006974];
embryonic cleavage [GO:0040016];
negative regulation of amyloid precursor protein biosynthetic process [GO:0042985];
negative regulation of apoptotic process [GO:0043066];
negative regulation of reactive oxygen species metabolic process [GO:2000378];
negative regulation of superoxide anion generation [GO:0032929];
positive regulation of transcription from RNA polymerase II promoter [GO:0045944];
regulation of mitotic cell cycle [GO:0007346];
ribosome biogenesis [GO:0042254]
Gene Ontology
(Molecular Function)
Complete annatation
leucine zipper domain binding [GO:0043522];
poly(A RNA binding [GO:0044822];
transcription factor activity, sequence-specific DNA binding [GO:0003700]
Gene Ontology
(Cellular Component)
Complete annatation
centrosome [GO:0005813];
cytoplasm [GO:0005737];
focal adhesion [GO:0005925];
Golgi apparatus [GO:0005794];
nucleolus [GO:0005730];
nucleus [GO:0005634]
Protein-protein interaction117743
Phylogenetic treeQ9NY61
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.160300836060360.0004830233781448760.0019310685292837
AZA vs. DISU0.02062214094258530.9351568747444970.995042856396371
AZA vs. IL70.1925739882845710.3183141196714760.999311006273513
AZA vs. SAHA-0.2090830613215980.3928346037452070.75485448488067
DISU vs. CD3-1.151339701804340.001815247112022860.00689940367287759
DISU vs. IL70.1624260137273280.5197112357296220.836588027616022
DISU vs. SAHA-0.2280983421222240.4344222190026380.781565866370867
DMSO vs. AZA0.01886004680654930.9108669754485621
DMSO vs. CD3-1.150937944231880.0003957072591099790.00152074741288057
DMSO vs. DISU-0.003186639723622310.9895962208204590.99806609310612
DMSO vs. IL70.180757155218240.3165477680276020.797189703271907
DMSO vs. SAHA-0.2348440291411980.3205092006021750.673695141182061
HIV vs. Mock in Activation0.03390673051086350.9566642955540320.999983755607037
HIV vs. Mock in Latency0.03949468350676960.8117693336731590.999834320637052
IL7 vs. CD3-0.9609352360404670.003130343452031450.0112987707980053
SAHA vs. CD3-1.39337595420570.000114390688765620.000542267278923527
SAHA vs. IL7-0.4042940527842110.09799225462626520.28362811947702
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.12897 0.409256
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.955 0.917 0.797 0.699 0.772
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found